Merck & Co Inc (MRK)
100.18
+0.32
(+0.32%)
USD |
NYSE |
Nov 22, 13:35
Merck Stock Buybacks (Quarterly): 444.00M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 444.00M |
June 30, 2024 | 251.00M |
March 31, 2024 | 122.00M |
December 31, 2023 | 393.00M |
September 30, 2023 | 466.00M |
June 30, 2023 | 338.00M |
March 31, 2023 | 149.00M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 18.00M |
September 30, 2021 | 583.00M |
June 30, 2021 | 239.00M |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 1.281B |
December 31, 2019 | 1.05B |
September 30, 2019 | 1.405B |
June 30, 2019 | 1.235B |
March 31, 2019 | 1.09B |
December 31, 2018 | 5.933B |
September 30, 2018 | 996.00M |
Date | Value |
---|---|
June 30, 2018 | 1.596B |
March 31, 2018 | 566.00M |
December 31, 2017 | 1.702B |
September 30, 2017 | 159.00M |
June 30, 2017 | 1.134B |
March 31, 2017 | 1.019B |
December 31, 2016 | 1.016B |
September 30, 2016 | 845.00M |
June 30, 2016 | 660.00M |
March 31, 2016 | 913.00M |
December 31, 2015 | 1.181B |
September 30, 2015 | 1.281B |
June 30, 2015 | 709.00M |
March 31, 2015 | 1.015B |
December 31, 2014 | 1.62B |
September 30, 2014 | 2.67B |
June 30, 2014 | 2.246B |
March 31, 2014 | 1.167B |
December 31, 2013 | 196.00M |
September 30, 2013 | 215.00M |
June 30, 2013 | 5.525B |
March 31, 2013 | 580.00M |
December 31, 2012 | 1.152B |
September 30, 2012 | 454.00M |
June 30, 2012 | 529.00M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
1.281B
Maximum
Mar 2020
280.74M
Average
149.00M
Median
Mar 2023
Stock Buybacks (Quarterly) Benchmarks
Amgen Inc | -- |
Johnson & Johnson | 539.00M |
Eli Lilly and Co | 446.10M |
Pfizer Inc | -- |
Moderna Inc | -8.00M |